Metabolic syndrome and coronary artery calcification in renal transplant recipients

Transplantation

Volumn 86, Issue 5, 2008, Pages 728-732

  Adeseun, Gbemisola A ^a   Rivera, Maria E ^a   Thota, Subhashini ^a   Joffe, Marshall ^a   Rosas, Sylvia E ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE   (United States)

Author keywords

Coronary calcifications; Metabolic syndrome; Renal transplantation

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; LIPID; TRIACYLGLYCEROL;

ADULT; ARTERY CALCIFICATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; BLOOD; BODY MASS; CALCINOSIS; OBESITY; POSTOPERATIVE COMPLICATION; PREVALENCE;

ADULT; BODY MASS INDEX; CALCINOSIS; CORONARY DISEASE; HUMANS; KIDNEY TRANSPLANTATION; LIPIDS; METABOLIC SYNDROME X; OBESITY; POSTOPERATIVE COMPLICATIONS; PREVALENCE; TRIGLYCERIDES;

EID: 53449093534     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181826d12     Document Type: Article

References (37)

1. Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006; 82: 603.
2. Marcen R. Cardiovascular risk factors in renal transplantation - Current controversies. Nephrol Dial Transplant 2006; 21 (Suppl 3): iii3-iii8.
3. Ojo AO, Hanson JA, Wolfe RA, et al. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57: 307.
4. Diaz JM, Sainz Z, Guirado LL, et al. Risk factors for cardiovascular disease after renal transplantation. Transplant Proc 2003; 35: 1722.
5. Ducloux D, Kazory A, Chalopin JM. Predicting coronary heart disease in renal transplant recipients: A prospective study. Kidney Int 2004; 66: 441.
6. deMattos AM, Prather J, Olyaei AJ,et al. Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors. Kidney Int 2006; 70: 757.
7. Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006; 47: 1093.
8. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683.
9. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245.
10. Porrini E, Delgado P, Bigo C, et al. Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation. Am J Kidney Dis 2006; 48: 134.
11. de Vries AP, Bakker SJ, van Son WJ, et al. Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally. Am J Transplant 2004; 4: 1675.
12. Dimeny E, Fellstrom B. Metabolic abnormalities in renal transplant recipients. Risk factors and predictors of chronic graft dysfunction? Nephrol Dial Transplant 1997; 12: 21.
13. Armstrong KA, Campbell SB, Hawley CM, et al. Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients. Am J Transplant 2005; 5: 2710.
14. Fazelzadeh A, Mehdizadeh A, Ostovan MA, et al. Incidence of cardiovascular risk factors and complications before and after kidney transplantation. Transplant Proc 2006; 38: 506.
15. Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005; 16: 496.
16. Hjelmesaeth J, Hartmann A, Midtvedt K, et al. May Metabolic cardiovascular syndrome after renal transplantation. Nephrol Dial Transplant 2001; 16: 1047.
17. National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in a 2002 Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. [Comment]. Circulation 106: 3143.
18. Rumberger JA, Brundage BH, Rader DJ, et al. Electron beam computed tomographic coronary calcium scanning: A review and guidelines for useinasymptomatic persons. [Erratum appears in Mayo Clin Proc1999 May;74:538]. Mayo Clinic Proc 1999; 74: 243.
19. Haydar AA, Hujairi NM, Covic AA, et al. Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant 2004; 19: 2307.
20. Raggi P. Role of electron-beam computed tomography and nuclear stress testing in cardiovascular risk assessment. Am J Cardiol 2005; 96: 20J-27J.
21. Ellison RC, Zhang Y, Wagenknecht LE, et al. Relation of the metabolic syndrome to calcified atherosclerotic plaque in the coronary arteries and aorta. Am J Cardiol 2005; 95: 1180.
22. Wong ND, Sciammarella MG, Polk D, et al. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol 2003; 41: 1547.
23. Arad Y, Newstein D, Cadet F, et al. Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arterioscler Thromb Vasc Biol 2001; 21: 2051.
24. Rosas SE, Mensah K, Weinstein RB, et al. Coronary artery calcification in renal transplant recipients. Am J Transplant 2005; 5: 1942.
25. OschatzE,BeneschT,KodrasK,et al. Changesofcoronary calcification after kidney transplantation. Am J Kidney Dis 2006; 48: 307.
26. Schankel K, Robinson J, Bloom RD, et al. Determinants of coronary artery calcification progression in renal transplant recipients. Am J Transplant 2007; 7: 2158.
27. Landis J, Gaughan C, Joffe M. Inter-laboratory serum creatinine (sCr) calibration study [abstract]. J Am Soc Nephrol 2003; 14: 294A.
28. Deleted in proof.
29. Courivaud C, Kazory A, Simula-Faivre D, et al. Metabolic syndrome and atherosclerotic events in renal transplant recipients. Transplantation 2007; 83: 1577.
30. Faenza A, Fuga G, Nardo B, et al. Metabolic syndrome after kidney transplantation. Transplant Proc 2007; 39: 1843.
31. Sharples E, Pereira D, Summers S, et al. Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients. Am J Kidney Dis 2004; 43: 313.
32. Robinson J, Tan AU, Wilensky RL, et al. Electron-beam computerized tomography correlates with coronary angiogram inchronic kidney disease patients. Am J Nephrol 2007; 27: 247.
33. Wong ND, Rozanski A, Gransar H, et al. Metabolic syndrome and diabetes are associated with an increased likelihood of inducible myo-cardial ischemia among patients with subclinical atherosclerosis. Diabetes Care 2005; 28: 1445.
34. Matsuoka M, Iseki K, Tamashiro M, et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004; 8: 54.
35. Blacher J, Guerin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938.
36. Block GA, Raggi P, Bellasi A, et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007; 71: 438.
37. LemieuxI,HoudeI,PascotA,et al. Effectsofprednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients. Kidney Int 2002; 62: 1839.